Minerva Neurosciences, Inc.
NERV
$5.21
-$0.29-5.27%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -283.67M | -2.74M | -3.26M | -3.75M | -4.27M |
| Total Depreciation and Amortization | 1.40K | 1.40K | 1.40K | 1.40K | 1.40K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 279.67M | 272.90K | 298.20K | 297.20K | 249.70K |
| Change in Net Operating Assets | -485.20K | -446.40K | 916.90K | -617.60K | -1.15M |
| Cash from Operations | -4.48M | -2.92M | -2.04M | -4.07M | -5.17M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 80.00M | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -5.50M | -45.20K | -- | -- | -- |
| Cash from Financing | 74.50M | -45.20K | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.02M | -2.96M | -2.04M | -4.07M | -5.17M |